Literature DB >> 28729456

Mechanistic Multi-Tissue Modeling of Glucocorticoid-Induced Leucine Zipper Regulation: Integrating Circadian Gene Expression with Receptor-Mediated Corticosteroid Pharmacodynamics.

Vivaswath S Ayyar1, Debra C DuBois1, Richard R Almon1, William J Jusko2.   

Abstract

The glucocorticoid-induced leucine zipper (GILZ) is an important mediator of anti-inflammatory corticosteroid action. The pharmacokinetic/pharmacodynamic/pharmacogenomic effects of acute and chronic methylprednisolone (MPL) dosing on the tissue-specific dynamics of GILZ expression were examined in rats. A mechanism-based model was developed to investigate and integrate the role of MPL and circadian rhythms on the transcriptional enhancement of GILZ in multiple tissues. Animals received a single 50-mg/kg intramuscular bolus or a 7-day 0.3-mg/kg/h subcutaneous infusion of MPL and were euthanized at several time points. An additional group of rats were euthanized at several times and served as 24-hour light/dark (circadian) controls. Plasma MPL and corticosterone concentrations were measured by high-performance liquid chromatography. The expression of GILZ and glucocorticoid receptor (GR) mRNA was quantified in tissues using quantitative real-time reverse-transcription polymerase chain reaction. The pharmacokinetics of MPL were described using a two-compartment model. Mild-to-robust circadian oscillations in GR and GILZ mRNA expression were characterized in muscle, lung, and adipose tissues and modeled using Fourier harmonic functions. Acute MPL dosing caused significant down-regulation (40%-80%) in GR mRNA and enhancement of GILZ mRNA expression (500%-1080%) in the tissues examined. While GILZ returned to its rhythmic baseline following acute dosing, a new steady-state was observed upon enhancement by chronic dosing. The model captured the complex dynamics in all tissues for both dosing regimens. The model quantitatively integrates physiologic mechanisms, such as circadian processes and GR tolerance phenomena, which control the tissue-specific regulation of GILZ by corticosteroids. These studies characterize GILZ as a pharmacodynamic marker of corticosteroid actions in several tissues.
Copyright © 2017 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28729456      PMCID: PMC5596815          DOI: 10.1124/jpet.117.242990

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  58 in total

1.  Modeling of corticosteroid effects on hepatic low-density lipoprotein receptors and plasma lipid dynamics in rats.

Authors:  Anasuya Hazra; Nancy A Pyszczynski; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  Pharm Res       Date:  2007-08-03       Impact factor: 4.200

2.  Pharmacogenomic responses of rat liver to methylprednisolone: an approach to mining a rich microarray time series.

Authors:  Richard R Almon; Debra C Dubois; Jin Y Jin; William J Jusko
Journal:  AAPS J       Date:  2005-08-18       Impact factor: 4.009

3.  Pharmacodynamics and pharmacogenomics of methylprednisolone during 7-day infusions in rats.

Authors:  Rohini Ramakrishnan; Debra C DuBois; Richard R Almon; Nancy A Pyszczynski; William J Jusko
Journal:  J Pharmacol Exp Ther       Date:  2002-01       Impact factor: 4.030

Review 4.  Merging systems biology with pharmacodynamics.

Authors:  Ravi Iyengar; Shan Zhao; Seung-Wook Chung; Donald E Mager; James M Gallo
Journal:  Sci Transl Med       Date:  2012-03-21       Impact factor: 17.956

5.  Tissue-specific regulation of glucocorticoid receptor mRNA by dexamethasone.

Authors:  J E Kalinyak; R I Dorin; A R Hoffman; A J Perlman
Journal:  J Biol Chem       Date:  1987-08-05       Impact factor: 5.157

Review 6.  Regulation of cytoplasmic mRNA decay.

Authors:  Daniel R Schoenberg; Lynne E Maquat
Journal:  Nat Rev Genet       Date:  2012-03-06       Impact factor: 53.242

7.  A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death.

Authors:  F D'Adamio; O Zollo; R Moraca; E Ayroldi; S Bruscoli; A Bartoli; L Cannarile; G Migliorati; C Riccardi
Journal:  Immunity       Date:  1997-12       Impact factor: 31.745

8.  A microarray analysis of the temporal response of liver to methylprednisolone: a comparative analysis of two dosing regimens.

Authors:  Richard R Almon; Debra C DuBois; William J Jusko
Journal:  Endocrinology       Date:  2007-02-15       Impact factor: 4.736

9.  Glucocorticoid-induced leucine zipper is an endogenous antiinflammatory mediator in arthritis.

Authors:  Elaine Beaulieu; Devi Ngo; Leilani Santos; Yuan Hang Yang; Malcolm Smith; Christian Jorgensen; Virginie Escriou; Daniel Scherman; Gabriel Courties; Florence Apparailly; Eric F Morand
Journal:  Arthritis Rheum       Date:  2010-09

10.  Mechanistic modeling of the effects of glucocorticoids and circadian rhythms on adipokine expression.

Authors:  Siddharth Sukumaran; William J Jusko; Debra C DuBois; Richard R Almon
Journal:  J Pharmacol Exp Ther       Date:  2011-03-11       Impact factor: 4.030

View more
  9 in total

1.  Receptor/gene/protein-mediated signaling connects methylprednisolone exposure to metabolic and immune-related pharmacodynamic actions in liver.

Authors:  Vivaswath S Ayyar; Siddharth Sukumaran; Debra C DuBois; Richard R Almon; Jun Qu; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-04-27       Impact factor: 2.745

2.  Modeling Corticosteroid Pharmacokinetics and Pharmacodynamics, Part I: Determination and Prediction of Dexamethasone and Methylprednisolone Tissue Binding in the Rat.

Authors:  Vivaswath S Ayyar; Dawei Song; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  J Pharmacol Exp Ther       Date:  2019-06-13       Impact factor: 4.030

3.  Modeling Corticosteroid Pharmacokinetics and Pharmacodynamics, Part II: Sex Differences in Methylprednisolone Pharmacokinetics and Corticosterone Suppression.

Authors:  Vivaswath S Ayyar; Debra C DuBois; Toshimichi Nakamura; Richard R Almon; William J Jusko
Journal:  J Pharmacol Exp Ther       Date:  2019-06-13       Impact factor: 4.030

Review 4.  Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids.

Authors:  Vivaswath S Ayyar; William J Jusko
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

5.  Modeling Corticosteroid Pharmacokinetics and Pharmacodynamics, Part III: Estrous Cycle and Estrogen Receptor-Dependent Antagonism of Glucocorticoid-Induced Leucine Zipper (GILZ) Enhancement by Corticosteroids.

Authors:  Vivaswath S Ayyar; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  J Pharmacol Exp Ther       Date:  2019-06-13       Impact factor: 4.030

Review 6.  Glucocorticoid-Induced Leucine Zipper: Fine-Tuning of Dendritic Cells Function.

Authors:  Mathias Vétillard; Géraldine Schlecht-Louf
Journal:  Front Immunol       Date:  2018-06-04       Impact factor: 7.561

Review 7.  Could GILZ Be the Answer to Glucocorticoid Toxicity in Lupus?

Authors:  Jacqueline K Flynn; Wendy Dankers; Eric F Morand
Journal:  Front Immunol       Date:  2019-07-17       Impact factor: 7.561

Review 8.  GR Dimerization and the Impact of GR Dimerization on GR Protein Stability and Half-Life.

Authors:  Ann Louw
Journal:  Front Immunol       Date:  2019-07-17       Impact factor: 7.561

Review 9.  Circadian rhythms: influence on physiology, pharmacology, and therapeutic interventions.

Authors:  Vivaswath S Ayyar; Siddharth Sukumaran
Journal:  J Pharmacokinet Pharmacodyn       Date:  2021-04-01       Impact factor: 2.745

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.